Results 1 to 10 of about 3,278,572 (256)

Human genetics of meningococcal infections. [PDF]

Hum Genet, 2020
Neisseria meningitidis is a leading cause of bacterial septicaemia and meningitis worldwide. Meningococcal disease is rare but can be life threatening with a tendency to affect children.
Hodeib S, Herberg JA, Levin M, Sancho-Shimizu V.   +3 more
europepmc   +2 more sources

Meningococcal infections among refugees and immigrants: silent threats of past, present and future. [PDF]

Hum Vaccin Immunother, 2020
Globally, there is an increasing number of international migrants. The majority are forced displaced refugees and children unaccompanied by a caregiver, and have limited access to essential public health interventions.
Dinleyici EC, Borrow R.
europepmc   +2 more sources

Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. [PDF]

Virulence, 2019
The complement system is pivotal in the defense against invasive disease caused by Neisseria meningitidis (Nme, meningococcus), particularly via the membrane attack complex.
Muenstermann M, Strobel L, Klos A, Wetsel RA, Woodruff TM, Köhl J, Johswich KO.   +6 more
europepmc   +2 more sources

Is meningococcal B vaccination needed in the post-COVID-19 world? [PDF]

Biomédica: revista del Instituto Nacional de Salud
Neisseria meningitidis is the main cause of bacterial meningitis worldwide and is transmitted through respiratory secretions. Meningitis is a serious public health problema because of its high morbidity and mortality rates and the risk of causing ...
Amanda Izeli Portilho, Elizabeth De Gaspari   +1 more
doaj   +2 more sources

W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012 [PDF]

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2012
From January to April 2012, 16 cases of W135 invasive meningococcal infection were reported in France. Of these, eight were linked to a recent travel history to Sub-Saharan Africa.
Isabelle Parent du Châtelet, Philippe Barboza, Muhamed‐Kheir Taha   +2 more
openalex   +2 more sources

Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications. [PDF]

PLoS ONE
IntroductionComplement component 5 inhibitor therapies (C5ITs) for rare hematological, renal, and neurological diseases are associated with increased meningococcal infection risk. Robust risk mitigation measures include vaccination, drug safety programs,
Cynthia Carrillo Infante, Arshad Mujeebuddin   +1 more
doaj   +2 more sources

Antibiotics for preventing meningococcal infections. [PDF]

Cochrane Database Syst Rev, 2013
Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L.   +4 more
europepmc   +3 more sources

Long-Term Protection Against Invasive Meningococcal B Disease and Gonococcal Infection 5 Years After Implementation of Funded Childhood and Adolescent 4CMenB Vaccination Program in South Australia: An Observational Cohort and Case-Control Study. [PDF]

Clin Infect Dis
Wang B, Giles L, Andraweera P, McMillan M, Beazley R, Almond S, Lally N, Bell C, Flood L, Ward J, Marshall H.   +10 more
europepmc   +3 more sources

Meningococcal infections in Scotland 1972–82 [PDF]

Journal of Hygiene, 1984
R.J. Fallon, William M. Brown, W Lore
openalex   +2 more sources

Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections [PDF]

Blood, 2006
T. Sprong
openalex   +2 more sources